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1. Introduction
Coronary artery bypass graft (CABG) operations are one of the most commonly performed sur‐
gical procedures, with a worldwide prevalence of over 800,000 annually and more than 350,000
operations being performed in the United States each year [1]. The use of the left internal mam‐
mary artery (LIMA) is widely considered to be the gold standard for conventional CABG opera‐
tions. Its use has been shown to result in a lower incidence of reintervention, fewer myocardial
infarctions, a lower incidence of angina, and lower associated mortality rates than with the use
of saphenous vein grafts alone. Also when compared to saphenous vein grafts, LIMA use has
been shown to have greater long-term patency results [1, 2]. For patients with multivessel coro‐
nary disease undergoing what is usually referred to as conventional CABG, the LIMA is typical‐
ly grafted to the left anterior descending (LAD) artery with saphenous vein grafts often used to
bypass the remaining coronary occlusions. However, arterial conduits are now being more fre‐
quently used as choices for the second and third conduits in place of saphenous vein grafts to
achieve total arterial revascularization (TAR) of the myocardium due to superior patency and
long-term survival results. This article provides a review of TAR using the right internal mam‐
mary artery (RIMA) and radial artery as additional arterial conduits in conjunction with the LI‐
MA as a first choice conduit. The reported benefits of TAR when compared to conventional
CABG procedures using the LIMA and saphenous vein grafts are discussed.
2. LIMA use in CABG
The LIMA is widely considered to be the best conduit for CABG procedures. In a study of the
Society of Thoracic Surgeons National Cardiac Database performed by Tabata et al., data from
541,368 CABG surgeries taking place between 2002 and 2005 were analyzed. Among all
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procedures performed, 92.4% of patients had at least one IMA graft, and the frequency of LIMA
usage by each hospital ranged from 48.0% to 100% with a median of 94% [3]. The presence of
an IMA graft has also been identified as an independent predictor of survival and confers
significantly better long-term survival rates than the use of saphenous vein grafts alone [2].
While anatomically identical to the LIMA, the RIMA is rarely used in CABG procedures, and
is almost always used as part of bilateral internal mammary artery (BIMA) grafts when it is
utilized. Despite several studies showing that BIMA use confers significantly improved clinical
outcomes [4-6], between 2003 and 2005 the frequency of BIMA use was only 4% [3]. Reasons
for not using the RIMA include increased operative time and perceived technical difficulty
associated with the harvest, concern for perioperative morbidity and mortality, the possibility
of reoperations for bleeding, sternal wound infection, and uncertainty as to whether there is
a significant benefit with BIMA grafting [7, 8]
3. Outcomes of BIMA in CABG
Despite its low prevalence of use, many studies have shown that RIMA use in conjunction
with the LIMA can confer significantly better clinical outcomes when compared to conven‐
tional CABG procedures with the LIMA and saphenous vein grafts.
Survival benefits of BIMA versus Single Internal Mammary Artery (SIMA)
Several observational, retrospective studies have found that there are significantly greater
long-term survival benefits in patients who received BIMA grafting compared to SIMA
grafting. Lytle et al. studied 10,124 elective CABG patients receiving either SIMA or BIMA
grafts with or without any additional vein grafts in a retrospective, non-randomized study
with a mean follow-up of 10 post-operative years. Hospital mortality rates were identical for
the SIMA and BIMA groups (0.7%). However, over 12 years of post-operative follow up,
survival rates for BIMA patients were significantly better than for SIMA patients (79.1% versus
71.6% respectively, p < 0.001) [9]. In a follow-up to the original study, which extended the mean
post-operative follow up to 16.5 years, survival rates for BIMA and SIMA patients at 20 years
were 50% versus 37% respectively (p < 0.0001), demonstrating a significant long-term survival
advantage for patients receiving two internal mammary grafts compared to just one [10].
Nasso et al. aimed to determine whether or not there were significant benefits to using two
arterial conduits rather than just a single arterial conduit. 815 patients were randomized to one
of four revascularization strategies: in situ LIMA to LAD plus isolated RIMA Y graft, in situ
RIMA to LAD plus in situ LIMA, in situ LIMA to LAD plus free radial artery, and in situ LIMA
to LAD with saphenous vein grafts as a control. All revascularization groups received
saphenous vein grafts to bypass the remaining coronary occlusions, if needed. Although the
authors found no significant overall survival advantage between any of their revascularization
groups over a follow-up period of two years, there was a significant difference in survival
when considering cardiac event-free survival. Patients in groups receiving two arterial grafts
had significantly better cardiac event-free survival rates when compared to patients who only
Artery Bypass120
received a single internal mammary artery (LIMA) grafted to the LAD with saphenous vein
grafts. These arterial revascularization strategies were also seen to convey significantly better
cardiac event-free survival rates to elderly (> 75 years) patients as well. The study did not find
any significant differences in survival based on the choice of either the RIMA or the radial
artery as the second arterial conduit [11].
In the longest reported retrospective analysis of CABG procedures, ranging from 6 weeks to
32 years of follow up, Kurlansky et al. conducted a review of 4,584 isolated CABG procedures
between 1972 and 1994. When patient differences were accounted for and comparisons made
between 2,197 matched patients, survival was 16.5% for SIMA patients and 28.5% for BIMA
patients after 25 years (p = 0.001). The median survival for SIMA patients was 11.8 years
compared to 15.9 years for BIMA patients. There were no significant differences between the
two groups in the rates of non-fatal myocardial infarction, reoperation, percutaneous coronary
intervention, permanent stroke, or composite freedom from late adverse cardiac events. [12
The location of the distal anastomosis of the RIMA graft also does not appear to significantly
affect clinical outcomes of patients undergoing BIMA grafting. Kurlansky et al. performed a
propensity-matched study of 2,215 patients undergoing BIMA CABG procedures having the
RIMA grafted to either the right coronary system or to the left coronary system. In both the
matched and unmatched analyses, there was no significant difference in operative or late
mortality between the two groups. The median survival for propensity-matched patients in
both groups was 16.1 years (p = 0.671) [13]. In another study by Rankin et al. there were no
significant differences in long-term outcomes based on grafting territory of BIMA grafts as
long as they are anastomosed to the two largest coronary systems [14].
Not all studies have found significantly increased survival rates for BIMA use over SIMA use.
In a study performed by Dewar et al., there was not a significant difference in the 5 or 7-year
survival rates for patients undergoing either unilateral or bilateral IMA grafting with supple‐
mental vein grafts. 5-year survival rates for SIMA and BIMA revascularization for patients less
than 60 years of age were 94.4% and 94.8%, respectively (p = not significant). There was also
no significant difference in 5-year survival rates for patients over 60 years of age. However,
the authors did note that there was a trend in lower rates of angina in the patient group
receiving BIMA grafts less than 60 years of age [15].
4. Patency of RIMA versus LIMA
Patency is the most important determinant in long-term prognosis [7]. Due to the extremely
low prevalence of use for the RIMA, there have been few studies evaluating its patency
compared to the LIMA. However, the studies that have been performed suggest that the RIMA
has similar early and even long-term patency rates as the LIMA, especially when grafted to
similar coronary territories [17].
Fukui et al. reviewed the angiographic records of 705 patients undergoing BIMA CABG
procedures. Early angiography and 1-year angiographic results for RIMA patency are good,
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with an overall patency of 98.8% at early angiography and 94.3% at 1-year postoperative
follow-up compared to 99.1% and 97.0% for the LIMA at the same follow-up times (p = 0.7732
and p = 0.1288, respectively). In terms of grafting technique, at both early and 1-year angio‐
graphic follow up, there were no significant differences in the patencies of in situ versus free
RIMA grafts. For free RIMA grafts, there were also no significant differences in patency rates
between sites of proximal anastomoses (composite versus aorta). However, for the in situ
RIMA, patency rates were significantly better when anastomosed to the anterior coronary
territory when compared to other grafting methods (p < 0.0001)[16].
Tatoulis et al. evaluated the results of 991 consecutive RIMA postoperative CABG angiograms
taking place between 1986 and 2008. The main focus was graft patency, with grafts considered
non-patent if they had a greater than 80% stenosis, string sign, or total occlusion. When com‐
pared to the LIMA for identical grafting territories, there was no significant difference in RIMA
and LIMA patency. For the LAD, overall LIMA patency was 96.9% while overall RIMA patency
was 94.6% (p = 0.74). When grafted to the circumflex, LIMA patency was 90.7% versus RIMA pa‐
tency of 91.9% (p = 0.85). Long-term patency results for the RIMA were favorable as well, with
92% of 352 RIMA grafts in place for greater than 10 years being patent. RIMA patencies were al‐
ways better than radial artery or saphenous vein graft patencies. At 15 years, RIMA patency was
79% compared to 50.7% for saphenous vein grafts (p < 0.001). 15-year data were not available for
the radial artery; 10-year patency was 78% (p < 0.01 when compared to RIMA 10-year patency).
However, the authors noted that data for radial artery patency is limited [17].
There are a variety of grafting techniques for BIMA, such as in situ grafting versus Y/T-grafts
that may have an impact on patency rates. In a study by Glineur et al., 304 patients receiving
BIMA grafts were randomized to receive either an in situ RIMA graft or a Y-graft with the
RIMA anastomosed proximally to the in situ LIMA as an end-to-side graft. Follow-up angiog‐
raphy was performed at 6 months and the RIMA patency rate in both groups was 97% (p =
0.99) [18]. In a similar but slightly larger study, Calafiore et al. also found no significant
differences in patency rates between in situ and Y-graft RIMA grafts at both early (13 days)
and long-term (17 months) angiographic follow up [19]. A longer study by Hwang et al. studied
5-year angiographic patency results of BIMA grafting configurations. At 1 year of follow-up,
in situ RIMA patency rates were not significantly different than Y-graft RIMA patency rates
(92.5% versus 95.7%, respectively, p = 0.138). Similarly at 5 years of follow up, there were also
no significant differences in patency rates (92.5% in situ versus 92.4% Y-graft, p = 0.978) [20].
5. Myocardial infarction, cerebrovascular accidents, freedom from
reoperation, and quality of life
Stevens et al. report that patients undergoing BIMA CABG operations had significantly better
long-term freedom from myocardial infarction (MI) and from coronary reoperation. After 10
post-operative years, 85% of BIMA patients were free of myocardial infarction compared to
82% of patients receiving LIMA grafts (p = 0.001). 99% of BIMA patients also were free from
coronary reoperation compared to 98% of LIMA patients (p = 0.01) [4].
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While  Burfeind  et  al.  found  no  significant  difference  in  15-year  mortality  rates  for  pa‐
tients receiving single IMA grafts or multiple (bilateral) IMA grafts, they did find signifi‐
cant  differences  in  the  rates  of  MI  and  CABG  reoperation.  However,  these  rates  differ
based  on  the  definition  of  what  constitutes  a  patient  receiving  multiple  IMA grafts.  In
their study 1,067 patients that had undergone isolated CABG procedures were analyzed
by three different methods. In the first analysis (analysis I), patients were analyzed based
on  the  initial  surgical  strategy  for  revascularization  –  SIMA  or  BIMA  grafts.  However,
not all patients who were designated to receive BIMA grafts were able to be revascular‐
ized with multiple IMAs, and likewise some patients designated to receive SIMA grafts
ultimately received BIMA grafts.  Analyses II  and III  were therefore performed based on
the surgery the patient ultimately received and not the initial surgical strategy. Analysis
II defined “multiple IMA grafts” based on the number of distal anastomoses performed.
Therefore,  in  analysis  II,  multiple  coronary  systems  anastomosed  with  multiple  IMA
grafts  were  considered  “multiple  IMA  grafts”  as  well  as  a  single  coronary  system  se‐
quentially  anastomosed with  a  single  IMA graft.  In  analysis  III  only  multiple  coronary
systems  anastomosed  with  multiple  IMA  grafts  were  considered  to  be  “multiple  IMA
grafts.” In both analyses II and III,  Burfeind et al.  found that there were significantly re‐
duced rates  of  CABG reoperation in  patients  receiving multiple  IMA grafts  when com‐
pared to  patients  only  receiving  a  single  IMA graft  (analysis  II:  9.7% reop SIMA,  4.5%
BIMA  p  =  0.0095;  analysis  III:  9.7%  reop  SIMA,  3.4%  BIMA,  p  =  0.0026).  However,  in
analysis III there was also a significantly reduced rate of MI in BIMA patients when com‐
pared with SIMA patients (17.4% versus 11.6% for SIMA and BIMA patients, respective‐
ly, p = 0.0181) [6].
In their original retrospective study on BIMA versus SIMA grafting in elective CABG patients,
Lytle et al. also found that patients receiving BIMA grafts had significantly greater reoperation-
free survival rates after 12 post-operative years than patients receiving only SIMA grafts with
or without any additional vein grafts. BIMA patients had a reoperation-free survival of 76.8%
compared to the 62.4% reoperation-free survival rate of SIMA patients [9].
As previously mentioned, Nasso et al. found that patients receiving two arterial grafts had
significantly better long-term, cardiac-event free survival outcomes than patients who just
received a single arterial graft with or without additional saphenous vein grafts. As expected,
adverse cardiac events occurred significantly less frequently in the groups receiving two
arterial grafts versus the group receiving just one. There was no significant difference in the
occurrence of adverse cardiac events between the three groups receiving two arterial grafts.
Cerebrovascular complications occurred more frequently in the SIMA group, however this
difference was not significant. The authors note that this increased incidence of cerebrovas‐
cular complications may be due to the more extensive manipulation of the ascending aorta
needed in the SIMA group due to the greater number of proximal anastomoses [11].
Damgaard et al. performed a study to assess the health-related quality of life improvements in
patients undergoing traditional CABG procedures versus patients undergoing TAR CABG
procedures. 331 patients were randomized between the two revascularization techniques and
over 90% of patients responded to the questionnaire at the specified time points. Preopera‐
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tively, patient scores in all areas of the questionnaire were significantly lower than that of the
results of the standardized Danish population. Post-operatively, both revascularization
groups showed significant improvement in all areas at 3 months and 11 months, with the TAR
group showing improvement in the ‘social functioning’ category that was significantly higher
than the conventional revascularization group. There was no significant difference in post-
operative improvement in the categories ‘physical component summary,’ ‘bodily pain,’ and
‘vitality’ between the two revascularization groups [21].
6. Incidence of sternal wound infection, subset of patients benefiting from
BIMA, IMA harvesting techniques, and operative time in BIMA CABG
One of the main concerns amongst surgeons regarding the use of BIMA in CABG procedures
is the occurrence of sternal wound infections (SWI). When both internal mammary arteries are
harvested, blood supply to the sternum may be more severely compromised than in single
IMA procedures, thus increasing the risk for developing SWI. Various pre-operative and intra-
operative techniques have been used to prevent the incidence of SWI, such as the use of
prophylactic antibiotics, double gloving, and skeletonized IMA harvesting [7]. Skeletonized
IMA harvesting is thought to preserve the collateral blood supply to the sternum and reduce
the risk of infection [22].
Patients who are insulin-dependent diabetics, morbidly obese, or who have severe COPD are
at a higher risk of developing SWI (DSWI = deep sternal wound infection, definition varies)
and, in general, bilateral harvesting of the IMAs is avoided in these patients [7, 8].
In a study performed by Pevni et al., 1,515 consecutive patients underwent CABG procedures
with skeletonized BIMA grafting. In earlier studies, the authors state that, in their past
experience, patients with chronic lung disease, diabetic females, and obese diabetics repre‐
sented absolute contraindications to BIMA grafting for CABG procedures because of the risk
of SWI. However in this study, the authors found that there was no evidence of a relationship
between diabetes mellitus and DSWI in patients receiving skeletonized BIMA grafts, even with
a prevalence of diabetes mellitus of 34% in their patient population [23].
In a meta-analysis of 13 studies regarding BIMA CABG procedures and the harvesting
technique for the IMAs, Saso et al. found that skeletonizing the IMA as opposed to harvesting
it in a pedicled manner lowered the incidence of SWI by 60%. An even greater benefit of
skeletonized harvesting was noted in groups at an increased risk for SWI, such as in diabetic
patients. The authors also found that these decreased rates of SWI applied to the entire
spectrum of sternal infections, including mediastinitis [22].
Kurlansky et al. found a slightly higher incidence of SWI amongst diabetic patients receiving
BIMA grafting compared to diabetic patients receiving LIMA grafting, but the difference was
not significant. However, amongst patients receiving BIMA grafts, the presence of diabetes
did affect the occurrence of SWI. This suggests that, while the presence of diabetes mellitus
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could still be considered a risk factor for SWI, the risk is not increased by receiving BIMA
grafting [12].
One of the probable factors contributing to the low prevalence of BIMA use is the perceived
increased operative time required to harvest both IMAs [7]. However, few studies have
actually included operative time in their statistical analyses, most simply report aortic cross-
clamp and cardiopulmonary bypass times. Gansera et al. do report total operative time and
found that operative time was significantly increased for patients receiving BIMA grafting
compared to patients receiving SIMA grafting (189 minutes versus 164 minutes, respectively,
p = 0.00). However, the number of anastomoses in the BIMA group was significantly higher
than in the SIMA group (3.8 versus 3.1, respectively, p = 0.00), which could in part explain the
increased operative time observed [8].
7. Radial artery grafts as a second arterial conduit
The success of the LIMA in CABG procedures has lead surgeons to search for other arterial
conduits. The radial artery has become a popular choice as an additional arterial conduit in
attempts to achieve total arterial revascularization of the myocardium. There are numerous
advantages to using the radial artery, including its long length, exposure to systemic blood
pressures, and the fact that it is seldomly affected by atherosclerosis. However, the radial artery
has a thicker tunica media, which is thought to contribute to its greater vasoconstrictor
response than the IMA and could possibly lead to vessel occlusion. Thus, care must be taken
during operative harvesting and the use of calcium-channel blockers may ameliorate a
vasospastic response [24].
Like the LIMA, the radial artery has been shown to have significantly better short and long-
term patency results and outcomes than vein grafts. In the radial artery patency study (RAPS),
Desai et al. randomized 561 patients to receive a radial artery graft to either the inferior (right)
coronary territory or to the lateral (circumflex) coronary territory, with a saphenous vein graft
anastomosed to the opposite territory in each group as a control. All patients also received a
LIMA graft to the LAD, with the main endpoint of the study being 1-year angiographic
complete occlusion of the radial artery versus saphenous vein. In this definition of occlusion,
grafts displaying the string-sign would be considered patent. At the mean follow-up of 10.9
months, 13.6% of saphenous vein grafts were completely occluded and 8.6% of radial artery
grafts were completely occluded (p = 0.009). The authors also found that the patency of radial
artery grafts depends on the severity of the native vessel stenosis, with better patency results
corresponding with higher grades of stenosis. Thus, the authors recommend using the radial
artery for the most highly occluded coronary vessel after the LAD [25].
In a follow-up to the original RAPS study, Deb et al. extended the mean angiographic follow-
up time to 7.7 years, with 269 patients of the original 561 undergoing late angiography. The
primary endpoint was functional graft occlusion; vessels displaying narrowing or reduced
flow were considered occluded as well as vessels that were completely occluded. 12.0% of
radial artery grafts were determined to be functionally occluded compared with 19.7% of
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saphenous vein grafts (p = 0.03). For the secondary endpoint of complete occlusion, 8.9% of
radial artery grafts were completely occluded compared with 18.6% of saphenous vein grafts
(p = 0.002) [26].
Zacharias et al. compared 6-year outcomes in propensity matched CABG patients receiving
LIMA to LAD grafts who also received either radial artery grafts or vein grafts only. The
authors found that mortality rates were 67% and 98% greater in vein patients than in radial
artery patients after 1 and 6 years, respectively. While LIMA patencies were always signifi‐
cantly greater than both radial and vein patencies, 6-year radial graft patencies were system‐
atically greater than that of vein grafts, although the results failed to reach statistical
significance. Overall, the use of the radial artery as a second arterial conduit in LIMA to LAD
CABG patients is associated with improved long-term survival [27].
Collins et al. compared 142 patients receiving either radial artery or saphenous vein grafted to
the left circumflex coronary artery, with the end point being 5-year angiographic patency.
98.3% of radial artery grafts and 86.4% of saphenous vein grafts were found to be patent after
the 5-year angiographic study of 103 patients (p = 0.04). The rate of graft narrowing was also
significantly less in radial artery grafts compared to vein grafts, with narrowing occurring in
10% of patent radial artery grafts and 23% of patent saphenous vein grafts (p = 0.01) [28].
A smaller study by Cameron et al. also examined the 5-year angiographic patency results of
radial artery grafts. Grafts that displayed a string sign were considered not patent. With a
radial artery graft patency rate of 89%, the authors found that the radial artery had a patency
rate similar to that of other grafts, although the study was too small to determine whether or
not this result was statistically significant [29]. Acar et al. report similar results for radial artery
graft patencies when compared to the LIMA [30].
Not all studies of radial artery use have been favorable. In a review of 310 patients receiving
radial artery grafts between 1996 and 2001, Khot et al. found significantly lower patency rates
for radial artery grafts when compared to IMA grafts, and similar patency rates when
compared to saphenous vein grafts after a mean follow up of 565 ± 511 days. Patency rates of
radial artery grafts, LIMA grafts, and saphenous vein grafts were 51.3%, 90.3%, and 64.0%,
respectively. While patency rates were similar between radial artery and saphenous vein
grafts, there was a significantly higher incidence of severe disease in radial artery grafts (p =
0.0003). Women were also found to have significantly lower radial artery patency rates than
men [31]. However, Desai et al. specifically note that this study did not use randomized
controls, standardized surgical methods, concurrent pharmacology, or routine angiographic
follow-up that could lead to potential bias [25].
8. RIMA versus radial artery as a second choice arterial conduit
With favorable clinical results for both RIMA and radial artery use, it is then necessary to decide
which is the better choice as a second arterial conduit when attempting to achieve multiple
arterial revascularization.
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Ruttman et al. studied 1,001 patients undergoing CABG procedures either receiving RIMA
grafts or radial artery grafts as second conduits after LIMA grafts with or without concomitant
saphenous vein grafts added when necessary. Propensity-score matched analysis was
performed on the two patient groups to examine the short and long-term outcomes of BIMA
grafting versus LIMA plus radial artery grafting. Overall, the evidence provides strong
support for the use of the RIMA over the radial artery as a second choice arterial conduit.
Radial artery graft occlusion and disease rates were significantly higher than both IMA and
saphenous vein anastomoses, with occlusion/disease rates of 37.9%, 10.2%, and 20.9%,
respectively. Survival rates for BIMA grafting were 98.9% at 1, 3, and 5 years post-operatively,
compared with rates for the radial artery group of 96.8%, 96.3%, and 93.0% at the same post-
operative years. The BIMA group also had significantly higher rates of major cardiac and
cerebrovascular events-free survival than the radial artery group at the same yearly intervals
post-operatively [32].
In  a  10-year  prospective,  randomized  trial,  Hayward  et  al.  examined  angiographic  out‐
comes of patients receiving either a radial  artery,  RIMA, or saphenous vein graft  to the
second largest coronary target after the LAD, which was grafted with the LIMA. Patients
were randomized to two groups: those less than 70 years of age received either a radial
artery or RIMA as the second arterial conduit, and those greater than 70 years of age re‐
ceived either a radial artery or saphenous vein. At a mean follow up of 5.5 years, a total
of 350 patients between the two groups had angiography performed. In the first  group,
Kaplan-Meier  estimates  of  graft  patency were 89.8% for  the radial  artery and 83.2% for
the RIMA (p = 0.06). In the second group, patency estimates were 90.0% for the radial ar‐
tery and 87.0% for the saphenous vein (p = 0.29). With no significant difference in the pa‐
tency  rates  between  the  conduits  in  each  of  the  two  groups,  the  results  show that  the
choice of  conduit  for the second largest  coronary target does not significantly affect  pa‐
tency, giving surgeons flexibility in their revascularization plans [33].
9. Total Arterial Revascularization (TAR)
The clinical benefits of RIMA and radial artery use have been established, and many studies
have indirectly examined the results of TAR in patients receiving BIMA or radial artery grafts
without the need of concomitant saphenous vein grafts. However, few studies have specifically
compared the clinical outcomes of TAR to conventional CABG procedures.
In  a  prospective  study  by  Muneretto  et  al.,  200  patients  over  70  years  of  age  were
randomized into two groups either receiving TAR or conventional CABG (LIMA to LAD
with  additional  saphenous  vein  grafts  if  needed).  Even  though  31%  of  patients  in  the
TAR group received BIMA grafts, the incidence of perioperative sternal wound complica‐
tions was found to be 1% in both groups. At the mean follow up of 15 months, the inci‐
dence  of  cardiac-related  events  (MI,  angina,  coronary  angioplasty,  and  graft  occlusion)
was significantly higher in the conventional CABG group compared to patients receiving
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TAR. The presence of diabetes and hyperlipidemia had a negative impact on clinical out‐
come,  especially  in  patients  receiving  saphenous  vein  grafts  in  the  conventional  CABG
group.  Conventional  CABG  surgery  was  also  found  to  be  significantly  associated  with
coronary  graft  occlusion.  Overall,  at  follow-up,  TAR  resulted  in  improved  clinical  out‐
comes in patients undergoing CABG procedures when compared to conventional CABG
[34].
In a more recent, long-term study with a mean follow-up of 6 years, Chung et al.  exam‐
ined  503  patients  undergoing  isolated  CABG  procedures  for  three-vessel  coronary  dis‐
ease.  Patients  in  the  study  either  received  TAR  (117  patients)  or  conventional
revascularization (386 patients). In both the crude analysis and propensity-score matched
analysis,  there was no significant  difference in the rates of  death,  reintervention,  MI,  or
stroke  between the  patients  receiving  TAR or  conventional  CABG.  However,  the  study
did not examine graft patency. The authors conclude that, since the outcomes were simi‐
lar between the two groups, “the selection of conduit should be more liberal” [35].
Zacharias  et  al.  conducted  a  long-term  study  of  4,743  patients  undergoing  multivessel
CABG procedures  receiving either  TAR (612  patients)  or  conventional  CABG (4,131  pa‐
tients). Early, 30-day mortality was similar for both patient groups, with a 1.30% mortali‐
ty rate in the TAR group and a 1.67% mortality rate in the conventional group. Due to
significant differences in the patient cohort for the two groups, propensity-matched anal‐
yses were performed for the 12-year follow up. Late survival was found to be significant‐
ly  better  in  total  arterial  patients  with  three-vessel  disease  compared  to  conventional
CABG patients with three-vessel disease (p < 0.001). However, there was not a significant
difference in late survival between the two groups for patients with two-vessel disease (p
= 0.89). The authors also noted that the completeness of myocardial revascularization was
“critical for maximizing the achievable long-term benefits of total arterial grafting” [36].
10. Summary
Poor  long-term  patencies  of  saphenous  vein  grafts  coupled  with  the  greater  long  term
patency results of the LIMA as the gold standard conduit for CABG has prompted sur‐
geons to seek out additional arterial conduits [1,2]. Achieving total arterial revasculariza‐
tion of the myocardium would then be a natural progression for the procedure.
Since it is anatomically identical to the LIMA, the RIMA would be the next logical choice
in arterial conduits, yet is rarely used in CABG operations due to the perceived technical
difficulty of harvest and increased operating times, a higher risk of developing SWIs, and
previous  lack  of  long-term  studies  of  clinical  outcomes  [7,8].  However,  several  studies
have demonstrated significantly increased long-term survival rates for patients receiving
BIMA grafting compared to SIMA grafting [9-12].  BIMA patients  also have significantly
improved cardiac  event-free  survival  than SIMA patients  [4,  6,  9].  Patency rates  for  RI‐
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MA grafts have also been shown to be similar to those of the LIMA, even when consid‐
ering the sites  of  distal  anastomoses and the proximal  anastomosing techniques [16,  17,
18,  19,  20].  Further  studies  are  needed to  determine if  there  is  any significant  effect  on
operative length in BIMA grafting versus conventional CABG.
The incidence of SWI has been a significant concern for surgeons, especially among high-risk
patients such as the morbidly obese, insulin-dependent diabetics, and those with COPD. BIMA
harvesting is generally avoided in these patients [7, 8], however studies have shown that BIMA
harvesting in general does not significantly affect the incidence of SWIs [12, 23]. The risk of
SWI can be even further reduced with the use of skeletonized BIMA harvesting rather than
pedicled harvesting [22, 23].
Studies have shown that the radial artery is also a good choice for an arterial conduit after the
LIMA. Studies examining clinical outcomes and patency rates of the radial artery have been
mixed, with some studies showing better short-term patency rates than saphenous vein grafts
[25-28], while other studies have shown that radial artery outcomes are at least similar to those
for the RIMA and saphenous vein [11, 32, 33].
While not all studies have been favorable with regards to BIMA and radial artery use [11, 15,
32, 33], studies generally find patency rates and clinical outcomes of these two arterial conduits
are at least as good as the currently accepted standards of care, which should give surgeons
flexibility in their choice of conduits, ultimately leading to total arterial revascularization.
Studies in general have provided favorable results for TAR, with TAR at least being similar in
outcomes to conventional CABG [35]. Several studies have demonstrated that TAR, and the
use of arterial conduits in general, provides significantly better late survival (especially in
patients with three vessel coronary disease), cardiac event-free survival, and improved health-
related quality of life when compared to conventional CABG [11, 21, 36].
11. Conclusion
With favorable results for the use of arterial conduits and results that are at least as good as
those seen in conventional CABG, these results should allow surgeons flexibility in their choice
of conduits. Due to the significantly increased long-term survival advantages over saphenous
vein grafts, BIMA use should be particularly indicated for younger patients, with special
attempts to achieve TAR in patients with three vessel disease. Especially with skeletonized
harvesting, BIMA may be safe to use in high-risk patients for SWI, such as insulin-dependent
diabetics. BIMA use may also decrease the incidence of postoperative cerebrovascular events
due to the decreased manipulation of the ascending aorta if both IMAs are used in situ. The
radial artery is also a suitable conduit to use in conjunction with BIMA or as a second arterial
conduit if either the LIMA or RIMA is not suitable for use. This ultimate flexibility provided
by TAR should allow surgeons to determine their revascularization strategies not based on
the availability of conduits, but by the possible co-morbidities and post-operative complica‐
tions that may arise based on the patient in question.
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